Overactive Detrusor Clinical Trial
— DOOfficial title:
Plantarflexion Reduces Urgency and Peak Detrusor Pressure in Patients With Detrusor Overactivity
NCT number | NCT01837654 |
Other study ID # | 76/12 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | June 2012 |
Est. completion date | August 2012 |
Verified date | November 2018 |
Source | Assaf-Harofeh Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to find out whether plantarflexion has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).
Status | Completed |
Enrollment | 22 |
Est. completion date | August 2012 |
Est. primary completion date | August 2012 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: All patients with urodynamic detrusor overactivity Exclusion Criteria: Inability to perform plantarflexion due to mental or physical disability |
Country | Name | City | State |
---|---|---|---|
Israel | Assaf Harofe Medical Center | Be'er Ya'aqov |
Lead Sponsor | Collaborator |
---|---|
Assaf-Harofeh Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean Peak Detrusor Pressures | Mean peak detrusor pressures of each contraction | through test completion, an average of 10 minutes | |
Secondary | Severity of the Urgency by a 0-10 Visual Analogue Scale (VAS). | Following each wave, patients will be asked to grade the severity of the urgency by a 0 (minimum) to 10 (maximum) visual analogue scale (VAS). | through test completion, an average of 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05977634 -
Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder
|
N/A | |
Completed |
NCT02657057 -
Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB
|
N/A | |
Completed |
NCT01192568 -
Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder
|
Phase 4 | |
Recruiting |
NCT05895045 -
Yoga for Treatment of Overactive Bladder in Pediatric Patients
|
N/A | |
Completed |
NCT03451175 -
Reproductibility of Cystometry in Multiple Sclerosis Patient
|
N/A | |
Terminated |
NCT03080389 -
Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
|
||
Completed |
NCT01629433 -
Onabotulinumtoxina Intradetrusorial Injections and NGF Expression
|
Phase 4 | |
Completed |
NCT01781117 -
Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia
|
N/A | |
Terminated |
NCT00845338 -
Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity
|
Phase 2 | |
Completed |
NCT03388086 -
Efficacy of Two Onabotulinum Toxin Doses
|
||
Completed |
NCT04197466 -
Comparison of Different Treatments for Overactive Bladder Syndrome
|
N/A | |
Not yet recruiting |
NCT02009540 -
Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity
|
Phase 4 | |
Completed |
NCT04270526 -
Minimizing Pain During Office Intradetrussor Botox Injection
|
Phase 4 | |
Enrolling by invitation |
NCT06212661 -
Migraine Medication Effects on Urinary Symptoms
|
||
Completed |
NCT01408771 -
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
|
N/A |